Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus versus daily vitamin D supplementation in breastfed term infants born to vitamin D-deficient mothers
ACTRN12613001234707Phase 3Completed
- Sponsor
- Sunshine Hospital
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Pentavite and vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Sunshine Hospital. Primary endpoints: Proportion of subjects with 25-hydroxyvitamin D > 50 nmol/L and 25-hydroxyvitamin D level. Started Aug 2013; status: completed.
02
Drugs
Pentavitevitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on ACTRN12613001234707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001234707.